A way to block a pain pathway in animal models of chronic neuropathic pain including pain caused by chemotherapeutic agents and bone cancer pain suggesting a promising new approach to pain relief.
In research published in the medical journal Brain, Saint Louis University researcher Daniela Salvemini, Ph.D. and colleagues within SLU, the National Institutes of Health (NIH) and other academic institutions have discovered a way to block a pain pathway in animal models of chronic neuropathic pain including pain caused by chemotherapeutic agents and bone cancer pain suggesting a promising new approach to pain relief.
The scientific efforts led by Salvemini, who is professor of pharmacological and physiological sciences at SLU, demonstrated that turning on a receptor in the brain and spinal cord counteracts chronic nerve pain in male and female rodents. Activating the A3 receptor – either by its native chemical stimulator, the small molecule adenosine, or by powerful synthetic small molecule drugs invented at the NIH – prevents or reverses pain that develops slowly from nerve damage without causing analgesic tolerance or intrinsic reward (unlike opioids).
An Unmet Medical Need
Pain is an enormous problem. As an unmet medical need, pain causes suffering and comes with a multi-billion dollar societal cost. Current treatments are problematic because they cause intolerable side effects, diminish quality of life and do not sufficiently quell pain.
The most successful pharmacological approaches for the treatment of chronic pain rely on certain “pathways”: circuits involving opioid, adrenergic, and calcium channels.
For the past decade, scientists have tried to take advantage of these known pathways – the series of interactions between molecular-level components that lead to pain. While adenosine had shown potential for pain-killing in humans, researchers had not yet successfully leveraged this particular pain pathway because the targeted receptors engaged many side effects.
A Key to Pain Relief
In this research, Salvemini and colleagues have demonstrated that activation of the A3 adenosine receptor subtype is key in mediating the pain relieving effects of adenosine.
“It has long been appreciated that harnessing the potent pain-killing effects of adenosine could provide a breakthrough step towards an effective treatment for chronic pain,” Salvemini said. “Our findings suggest that this goal may be achieved by focusing future work on the A3AR pathway, in particular, as its activation provides robust pain reduction across several types of pain.”
The Latest on: Pain relief
via Google News
The Latest on: Pain relief
- Alabama research leads to new treatment for painful illnesson January 11, 2020 at 9:21 pm
During her training in hematology, she noticed a shortage of treatment options for sickle cell patients. Only one drug had been approved to reduce the disease’s hallmark pain crises. These bouts of ...
- CES 2020 Live, Day 2: The Latest in Health Tech for Pain Relief, Asthma, and Moreon January 11, 2020 at 1:46 am
Everyday Health is in Las Vegas all this week for the Consumer Electronics Show. We'll be bringing you a close-up look at the latest health and wellness technology, with live updates throughout the ...
- January 11 - WNY Pain Relief & Integrative Wellness Centeron January 10, 2020 at 6:25 pm
Until recently those suffering from back, neck or extremity pain were severely limited in their treatment options. But, at the WNY Pain Relief and Integrative Wellness Center, they can find your ...
- Cyber Security to Sinus Pain Relief – Top Picks from CES 2020on January 10, 2020 at 2:50 pm
Tech expert, Andrea Smith, shares her top picks from CES 2020 that are guaranteed to rock the industry and delight even the biggest tech nerds... including great new products from D6News.com ...
- The Week That Wasn't: Popcorn-Linked Infection, Minimum Wage, Altruistic Pain Reliefon January 10, 2020 at 12:14 pm
You may have recently seen articles about a man who needed open-heart surgery after eating popcorn and contracting a life-threatening infection, a link between increasing minimum wage and decreasing ...
- Topical Pain Relief Market Analysis, Size, Share, Growth and Opportunity Assessment till 2025on January 10, 2020 at 2:44 am
Global Topical Pain Relief Market valued approximately USD 7.48 billion in 2017 is anticipated to grow with a healthy growth rate of more than 7.42% over the forecast period 2018-2025. The Topical ...
- Certified Spine & Pain Care Introduces Multiple Pain Treatment Plans/Options In All Its Pain Management Clinicson January 9, 2020 at 11:21 pm
Certified Spine & Pain Care has introduced many different modalities for the treatment of chronic and acute pain. The pain clinic is now offering sacroiliac joint injections, lumbar sympathetic block, ...
- Pear Therapeutics acquires VR tech for pain treatmenton January 9, 2020 at 2:02 pm
Pear Therapeutics started the new year off with a bang: the digital health company acquired two technologies for pain treatment on Monday. Pear acquired the two clinical-stage digital therapeutics ...
- Global Pain Relief Patches Market 2020 Performance,Market Share, Analysis and forecast to 2024on January 8, 2020 at 9:20 pm
Global Pain Relief Patches Market comprehensive analysis of the business models, key ways, and individual market shares of some of the most outstanding players during this landscape. AN in-depth ...
- Greater back, leg pain relief seen with closed-loop spinal cord stimulationon January 8, 2020 at 7:14 am
According to study results, evoked compound action potential-controlled closed-loop spinal cord stimulation compared with fixed-output, open-loop spinal cord stimulation offered significantly greater ...
via Bing News